GB Patent

GB2463978B8 — Enhanced bioavailability of octreotide vis the GI tract using a suspension in a hydrophobic medium

Assigned to Amryt Endo Inc · Expires 2012-02-29 · 14y expired

What this patent protects

Patent listed against octreotide-acetate.

Drugs covered by this patent

octreotide-acetate (OCTREOTIDE ACETATE)

Patent Metadata

Patent number: GB2463978B8
Jurisdiction: GB
Classification: —
Expires: 2012-02-29
Drug substance claim: No
Drug product claim: No
Assignee: Amryt Endo Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.